Evidence map›Paper›PMID 37483247›Full record

ArticleACS omega2023

Mapping Peptide-Protein Interactions by Amine-Reactive Cleavable Photoaffinity Reagents.

Dimitris Korovesis, Vanessa P Gaspar, Hester A Beard, Suyuan Chen, René P Zahédi, Steven H L Verhelst

Open access · goldAbstract read
In one paragraph

Article in ACS omega, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Dimitris KorovesisLaboratory of Chemical Biology, Department of Cellular and Molecular Medicine, KU Leuven-University of Leuven, Herestraat 49 Box 802, Leuven 3000, Belgium.
Vanessa P GasparSegal Cancer Proteomics Centre, Lady Davis Institute for Medical Research and McGill University, Montreal, Quebec H3T 1E2, Canada.
Hester A BeardLaboratory of Chemical Biology, Department of Cellular and Molecular Medicine, KU Leuven-University of Leuven, Herestraat 49 Box 802, Leuven 3000, Belgium.ORCID https://orcid.org/0000-0002-7942-410X
Suyuan ChenAG Chemical Proteomics, Leibniz Institute for Analytical Sciences ISAS, e.V., Otto-Hahn-Str. 6b, Dortmund 44227, Germany.
René P ZahédiSegal Cancer Proteomics Centre, Lady Davis Institute for Medical Research and McGill University, Montreal, Quebec H3T 1E2, Canada.
Steven H L VerhelstLaboratory of Chemical Biology, Department of Cellular and Molecular Medicine, KU Leuven-University of Leuven, Herestraat 49 Box 802, Leuven 3000, Belgium.ORCID https://orcid.org/0000-0002-7400-1319
KU Leuven · BELeibniz Institute for Analytical Sciences - ISAS · DEMcGill University · CAResearch Manitoba · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Photoaffinity labeling followed by tandem mass spectrometry is an often used strategy to identify protein targets of small-molecule drugs or drug candidates, which, under ideal conditions, enables the identification of the actual drug binding site. In the case of bioactive peptides, however, identifying the distinct binding site is hampered because of complex fragmentation patterns during tandem mass spectrometry. We here report the development and use of small cleavable photoaffinity reagents that allow functionalization of bioactive peptides for light-induced covalent binding to their protein targets. Upon cleavage of the covalently linked peptide drug, a chemical remnant of a defined mass remains on the bound amino acid, which is then used to unambiguously identify the drug binding site. Applying our approach to known peptide-drug/protein pairs with reported crystal structures, such as the calmodulin-melittin interaction, we were able to validate the identified binding sites based on structural models. Overall, our cleavable photoaffinity labeling strategy represents a powerful tool to enable the identification of protein targets and specific binding sites of a wide variety of bioactive peptides in the future.

Identifiers

PMID37483247
PMCPMC10357517
OpenAlexW4383500228

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.